Skip to main content
BMC Gastroenterology logoLink to BMC Gastroenterology
. 2023 Jan 10;23:6. doi: 10.1186/s12876-022-02626-x

Establishing machine learning models to predict the early risk of gastric cancer based on lifestyle factors

Mohammad Reza Afrash 1, Mohsen Shafiee 2, Hadi Kazemi-Arpanahi 3,
PMCID: PMC9832798  PMID: 36627564

Abstract

Background

Gastric cancer is one of the leading causes of death worldwide. Screening for gastric cancer greatly relies on endoscopy and pathology biopsy, which are invasive and pose financial burdens. Thus, the prevention of the disease by modifying lifestyle-related behaviors and dietary habits or even the prevention of risk factor formation is of great importance. This study aimed to construct an inexpensive, non-invasive, fast, and high-precision diagnostic model using six machine learning (ML) algorithms to classify patients at high or low risk of developing gastric cancer by analyzing individual lifestyle factors.

Methods

This retrospective study used the data of 2029 individuals from the gastric cancer database of Ayatollah Taleghani Hospital in Abadan City, Iran. The data were randomly separated into training and test sets (ratio 0.7:0.3). Six  ML methods, including multilayer perceptron (MLP), support vector machine (SVM) (linear kernel), SVM (RBF kernel), k-nearest neighbors (KNN) (K = 1, 3, 7, 9), random forest (RF), and eXtreme Gradient Boosting (XGBoost), were trained to construct prognostic models before and after performing the relief feature selection method. Finally, to evaluate the models’ performance, the metrics derived from the confusion matrix were calculated via a test split and cross-validation.

Results

This study found 11 important influence factors for the risk of gastric cancer, such as Helicobacter pylori infection, high salt intake, and chronic atrophic gastritis, among other factors. Comparisons indicated that the XGBoost had the best performance for the risk prediction of gastric cancer.

Conclusions

The results suggest that based on simple baseline patient data, the ML techniques have the potential to start the prescreening of gastric cancer and identify high-risk individuals who should proceed with invasive examinations. Our model could also considerably lessen the number of cases that need endoscopic surveillance. Future studies are required to validate the efficacy of the models in a larger and multicenter population.

Keywords: Machine learning, Gastric cancer, Behavioral lifestyle, Prevention, Prognosis

Introduction

Gastric cancer (also known as stomach cancer) is the fourth most prevalent neoplastic disease and the second leading cause of cancer-related deaths worldwide [1]. Gastric cancer, with a yearly incidence of about 7300 individuals, is one of the five most prevalent malignancies in the Iranian population. This disease is the first cause of cancer-related deaths in both sexes in Iran because the majority of patients are diagnosed in the advanced stages of the disease. Moreover, the 5-year survival rate in Iran is estimated at less than 25% [2]. A large proportion of patients with gastric cancer typically have no specific symptoms, and some of the early signs in patients are similar to gastritis or indigestion; therefore, gastric cancer is easily disregarded by patients. By the time their symptoms are noticeable, most of the patients have developed advanced gastric cancer. As a result, cancer invades adjacent tissues, and in such cases, treatments are ineffective and challenging, and the patient dies in a short while. The 5-year chance of surviving gastric cancer in a patient diagnosed in the early stages is more than 80%, which is significantly higher than the survival rate of a patient diagnosed in the advanced stages [35], highlighting the urgent need for an early screening method to improve the detection of gastric cancer. Individuals with low-risk gastric cancer should also be monitored to minimize the likelihood of advancing to high-risk stages. Therefore, preventing risk factors that contribute to the formation and development of gastric cancer should be a priority in healthcare system programs [6].

Endoscopy along with pathology biopsy is the current gold standard in the screening and detection of gastric cancer [7]. However, some patients, especially in rural and remote areas, avoid endoscopy or surgery due to the invasive nature and cost of this procedure [8]. If an individual is predicted to have a high risk of developing gastric cancer, preventative measures can be taken in advance. On the other hand, if the prognosis indicates that the patient has a low risk of developing gastric cancer, endoscopic examinations of the upper gastrointestinal tract, which are associated with possible risks and high screening costs, can be avoided or minimized. A large-scale survey of 200,000 individuals who underwent endoscopic examinations revealed a side effect rate of 0.13% and a mortality rate of 0.004%. Therefore, endoscopic screening for gastric cancer has been suggested in several subgroups of patients at risk [9, 10]. A meta-analysis study conducted in 2018 showed that population-based endoscopic screening in Asian countries significantly reduces the risk of death from gastric cancer. However, establishing a population-based endoscopic screening program in clinical practice is neither cost-effective nor practical [11]. Hence, the adoption of non-invasive techniques or models for the diagnosis of gastric cancer is of great importance.

Thus far, no non-invasive measures have been taken to diagnose gastric cancer with high sensitivity and specificity. Early diagnosis of gastric cancer and the subsequent early treatment are crucial to improve survival and reduce mortality from this cancer. Therefore, due to the complexity and interlinking factors that are causally related to gastric cancer, it is increasingly urgent to adopt non-invasive and time-saving diagnostic methods with high accuracy to minimize imprecision and uncertainty in the diagnosis of gastric cancer.

The adoption of artificial intelligence (AI)-based solutions, such as machine learning (ML), can overcome the restrictions of invasive diagnostic procedures in the screening and diagnosis of gastric cancer due to their computational capacity. ML techniques are well-known tools for developing predictive and data analysis models and can implicitly extract useful information from raw datasets [12]. ML can extract hidden relationships and patterns from large and high-dimensional data in single- or multicenter datasets [13, 14]. ML models are automatically created based on training data that can be used to make inferences or decisions in uncertain conditions without being explicit programming [15]. By capturing multifaceted nonlinear relations in the datasets, ML algorithms can increase the prediction accuracy more than traditional statistics techniques [16, 17].

Many studies have used ML techniques to predict gastric cancer up until now. Liu et al. used ML to predict gastric cancer with an accuracy of 77% [18]. Cai et al. performed univariate and multivariate analyses for gastric cancer prediction using demographic, dietary, and medical history as input data [19]. Safdari et al. developed a system for earlier diagnosis of gastric cancer using fuzzy logic with a sensitivity of 92.1% and a specificity of 83.1% [20]. Su Y et al. detected gastric cancer using a decision tree (DT) classification of mass spectral data with an accuracy of 86.4% [21]. Brindha et al. utilized dietary and lifestyle features to predict etiological factors of early gastric cancer and trained several supervised ML algorithms, including naive Bayes, logistic regression (LR), and multilayer perceptron (MLP). Their results showed that naive Bayes has the best performance with an accuracy of 90% as compared to the other models [22]. Mortezagholi et al. employed endoscopy images as attributes for a case–control study using ML techniques, including the support vector machine (SVM), DT, naive Bayesian model, and k nearest neighborhood (KNN) to predict patients with gastric cancer [23]. They reported that SVM with an accuracy of 90.8% exhibits the best performance compared to the other models [8]. Taninaga et al. showed that eXtreme Gradient Boosting (XGBoost) outperformed LR in predicting gastric cancer using comprehensive longitudinal data with the highest area under the curve (AUC) value (0.899) [10]. Several studies have applied neural network methods to detect gastric cancer based on endoscopic images with high sensitivity [24, 25]. In the study of gastric cancer, ML techniques are mainly used to analyze endoscopic images, which are obtained through invasive methods [24, 26]. In contrast, analyzing lifestyle-related factors is non-invasive and inexpensive. Gastric cancer is largely reliant on lifestyle-related factors and can be prevented with a change of diet and habits [27]. Therefore, in this study, we aimed to predict gastric cancer based on lifestyle and historical data using ML methods. Thus far, numerous ML methods have been developed in the medical field. Each of these ML methods has a different algorithm and nature of work. If chosen appropriately, all these models will perform at their peak [28]. The selection of ML models is dependent on the data (the type and specific characteristics of each dataset, such as structured or unstructured, number of dimensions, number of samples, and other similar factors) as well as the desired performance [29]. In the current study, we chose six ML algorithms that performed well on structured and unstructured datasets and on datasets with several dimensions (SVM, KNN, random forest (RF)), an ML model that could solve complex nonlinear problems randomly (MLP), and a model that has the ability to set multiple hyperparameters to achieve high accuracy (XGBoost) [3033].

The structure of the manuscript is as follows: First, the dataset is presented. The ML techniques used in this paper are then described in detail. After that, the results of comparing ML techniques are shown. In the next stage, the most accurate model for predicting gastric cancer based on the results of performance evaluation metrics is reported.

Methods

Study design and experiment environment

This is a retrospective, single-center study that was conducted in 2022. A dataset was collected from the Ayatollah Taleghani database affiliated with Abadan University of Medical Sciences, Abadan City, Iran. Six ML-based models were developed for the prediction of gastric cancer using lifestyle-related factors. This study was conducted based on the cross-industry standard process for data mining (CRISP-DM). The prediction models were developed using Python programming language in five main CRISP stages including data understanding, pre-processing, feature selection, model training, and evaluation, as shown in the block diagram below (Fig. 1).

Fig. 1.

Fig. 1

Block diagram of the proposed system for gastric cancer risk prediction

Dataset description and participants

The dataset used in this study was obtained from the gastric cases referred to the internal clinic of Ayatollah Taleghani Hospital in Abadan, Iran, during 2015–2021. The patients’ information was reviewed and extracted by a health information management expert. The patients who were referred to the clinic for the screening, diagnosis, and treatment of gastric cancer were included in this study. A total of 2029 individuals (429 patients vs. 1780 healthy controls) participated in the study. The analyzed dataset contained descriptive information about the respondents (28 features) and the outcome of the gastric cancer risk (one feature), which can be viewed as the dependent variable (Table 1).

Table 1.

Gastric cancer variables

Variable name Values
Age (year) 18–94
Gender Male, female
BMI (kg/m2)  < 25, >  > 25
Blood type A Yes/No
Marital status Single, married
Family history of cancer Yes/No
Depression Yes/No
Stress status NO–mild–sever
Income level Lowest–middle–highest
Education level Uneducated, high school, university
Residence status Rural, town
High salt intake Yes/No
High fat foods status Yes/No
Alcohol consumption Yes/No
Smoking Yes/No
Physical activity Yes/No
Fruits intake Low–middle–high
Red meat consumption Low–middle–high
Gastric cancer screening Participated-did not participate
Weight loss Yes/No
Helicobacter pylori test Negative, positive
Upper abdominal fullness Yes/No
Abdominal pain Yes/No
Stomach polyp Yes/No
Recurrent nausea and vomiting Yes/No
Stomach or duodenal ulcers Yes/No
Previous stomach surgery Yes/No
Chronic atrophic gastritis Yes/No

Preprocessing the dataset

Data preprocessing is an essential step in the CRISP-DM method, and it has a significant impact on the performance of data mining techniques. The objectives of data preprocessing are to cleanse the outlier, remove the noisy data, impute missing values, and convert the data into a suitable format for more reliable and accurate data analysis. In the first phase of preprocessing steps, we employed the interquartile range rule to detect outliers and normalize the dataset by using the min–max method. To impute missing values, mean and regression-based methods were applied. We also deleted the rows with more than 70% missing values. The Z-score standardization method was used as a data distribution-based data scaling, and for data range-based scaling, the min–max method was employed. In the preprocessing phase, 240 records of the dataset were deleted, and after removing these records, the number of the cases of the dataset was reduced to 2029 records. Since group distribution in the dataset used for this study is imbalanced, one of the groups contains 1780 samples (healthy individuals) while the other has 429 samples (patients). Therefore, we created a new dataset by approximating the group with fewer samples (patient group = 429) to the group with a larger number of samples (healthy group = 1780 individuals), such that the samples of the group with fewer cases in the dataset are randomly reproduced. In this study, the synthetic minority oversampling technique (SMOTE) was applied to the resampling process. The SMOTE method is the most common and effective oversampling method, which is applied in various fields to balance the datasets [34, 35].

Feature selection

One of the fundamental issues with many data mining tasks is to determine and specify relationships between attributes in the dataset and outcome. Feature selection is one of the main phases of a successful data mining process, especially in problems with a large number of dimensions or variables in the dataset. Feature selection is defined as the process of determining relevant variables and removing irrelevant ones [36]. In the present study, the relief feature selection algorithm was implemented to reduce the number of features and combinations in order to obtain the most important predictors. Relief is a method for the random selection of relevant attributes based on variables' weight. This algorithm assigns weights to all the variables. The most important attributes to the outcome have higher weight values, whereas the other attributes have lower weights [37].

Training and evaluation of ML classifiers

In order to develop an early prediction model for gastric cancer risk, a total of six ML algorithms were used: MLP, SVM (linear kernel), SVM (RBF kernel), KNN (K = 1, 3, 7, 9), RF, and XGBoost. To implement these models, we experimentally tuned the hyperparameters on the training split of the dataset based on the cross-validation (CV) method. The performance of the ML algorithms was evaluated using the holdout technique, a method for out-of-sample assessment where the dataset was split into two parts (70% training and 30% test). The ML models were then trained on the first split of the dataset and tested on the other part. In addition, the K-fold CV method (K = 10) was applied to evaluate the performance of the best algorithms to overcome a feasible biased error estimate. Five performance evaluation metrics were selected and reported for each ML technique to compare the performance of classifiers, which is common in medical prediction studies. The performance evaluation metrics of the classifiers are listed below, along with their definitions:

classificationaccuracy=TP+TNTP+TN+FP+FN100 1
classificationsensitivity=TpTP+FN100 2
classificationspecificity=TNTN+FP100 3
classificationerror=FP+FNTP+TN+FP+FN100 4

Ethical consideration

This study was approved by the ethics committee board of Abadan University of Medical Sciences (Ethics code: IR.ABADANUMS.REC.1401.013). To protect the privacy and confidentiality of patients, we concealed the unique identification information of all patients in the process of data collection and presentation. The present study adhered to the principles expressed in the Declaration of Helsinki.

Results

Characteristics of patients

After applying the exclusion criteria and conducting a quantitative analysis of patients’ records, 2029 patients were found to be eligible. Of the 2029 participants in the study, 1094 (54%) were male and 1015 (46%) were female, and the age of the participants was between 18 and 94. In total, 1780 (88%) of the study subjects were healthy controls, and 429 (22%) were patients. The descriptive statistics for the 2029 samples in this dataset are shown in Table 2.

Table 2.

The descriptive statistics of variables

Variable name Total With gastric cancer (429) No gastric cancer(1780)
N N
Age >>40 505 23 482
40-65 937 147 790
65>> 767 259 508
Gender Male 1025 192 833
Female 1184 237 947
BMI (kg/m2) >25 1660 194 1466
<<25 549 235 314
Blood type A Yes 402 95 307
 No 1807 334 1473
Marital status Single 744 90 654
Married 1465 339 1126
Family history of cancer Yes 167 14 153
No 2042 415 1627
Depression status Yes 525 194 331
No 1684 235 1449
Stress status NO 626 36 590
Mild 1293 190 1103
Sever 290 203 87
Income level Lowest 1074 176 898
Middle 811 214 597
High 324 39 285
Education level Uneducated 360 47 313
high school 681 192 489
University 1168 190 978
Residence status Rural 656 84 572
Town 1553 345 1208
High salt intake Yes 1161 162 999
No 1048 267 781
High fat foods status Yes 1236 244 992
No 973 185 788
Alcohol consumption Yes 140 28 112
No 2069 401 1668
Smoking Yes 464 74 390
No 1745 355 1390
Physical activity Yes 651 52 599
No 1558 377 1181
Fruits consumption Low 416 114 302
Middle 1473 284 1189
High 320 31 289
Red meat consumption low 1377 86 1291
Middle 577 195 382
High 255 148 107
Gastric cancer screening Yes 370 14 356
No 1839 415 1424
Weight loss Yes 378 186 192
No 1831 243 1588
Helicobacter pylori infection Yes 307 174 133
No 1902 255 1647
Upper abdominal fullness Yes 501 286 215
No 1708 143 1565
Abdominal pain Yes 600 236 364
No 1609 193 1416
Stomach polyp Yes 210 80 130
No 1999 349 1650
Recurrent nausea and vomiting Yes 330 149 181
No 1879 280 1599
Stomach or duodenal ulcers Yes 322 217 105
No 1887 212 1675
Previous stomach surgery Yes 237 69 168
No 1972 360 1612
Chronic atrophic gastritis Yes 260 112 148
No 1949 317 1632

The results of selected features using the relief feature selection algorithm

A total of 11 features were selected due to their positive correlation with gastric cancer by performing the Relief feature selection algorithm. These features are Helicobacter pylori infection, high salt intake, chronic atrophic gastritis, consumption of fruits, stomach or duodenal ulcers, weight loss, consumption of high-fat foods, educational level, smoking, stress status, and weight. The key features selected by the Relief feature selection algorithm and their scores are presented in Table 3.

Table 3.

Variables selected by feature selection

Order Feature name Score
1 Helicobacter pylori infection 4.10
2 High salt intake 1.807
3 Chronic atrophic gastritis 1.802
4 Fruits consumption 1.59
5 Stomach or duodenal ulcers 1.45
6 Weight loss 1.42
7 High fat foods 1.36
8 Education level 1.34
9 Smoking 1.22
10 Stress status 1.19
11 Weight loss 1.14

Based on the results of the Relief feature selection algorithm (Table 3), Helicobacter pylori infection is three times more effective than the other attributes for the early prediction of gastric cancer. High salt intake, chronic atrophic gastritis, and low consumption of fruits are significantly associated with a high risk of gastric cancer. In contrast, weight loss and stress were ranked as the 10th and 11th most important risk factors in the prediction of gastric cancer, respectively (see Fig. 2).

Fig. 2.

Fig. 2

The most important features selected by the Relief feature selection algorithm

The results of the tuning of hyperparameters

In order to improve the performance of ML techniques, many methods can be used to tune hyperparameters. In this study, the randomized search CV method was employed for the tuning of parameters and the optimization of ML techniques. Table 4 indicates the best hyperparameter classifier for the early prediction of gastric cancer based on lifestyle factors.

Table 4.

Hyperparameters selected to be fed into the classifiers for the early prediction of gastric cancer

Num ML models Hyper-parameters F-score
1 RF (‘verbose’:2,’random_state’:888,’n_estimators’:10,’max_deph’:9,’criterion’: gini’) 85.31
2 MLP ‘Learning rate’ = ’constant’, hidden_layer_size’ = (80, 80, 80), ‘alpha’ = 0.08, ‘activation’ = ’rulo’ 87.6
3 SVM (kernel = linear) C = 100, G = 0.0001 83.04
4 SVM (kernel = RBF) C = 10, G = 0.001 81.9
5 XGBoost ‘min_chid_weigh’ = 1’max_depht’ = 14,’learning_rate’ = 0.2, ‘gamma’ = 0.4, ‘colsample_bytree’ = 0.5 81.02

The results of k-fold CV for classifiers’ performance on full features and selected features

In the present study, full features and features selected by the Relief feature selection algorithm were tested on six classification algorithms using the 10-fold CV methods. In the tenfold CV method, 90% of the dataset was used for training the algorithms and only 10% was tested. The mean metrics of tenfold methods were measured. Additionally, different metrics values were passed through classification algorithms. At first, we trained and tested the data mining algorithms with all the dataset features. Then we fed 11 features into the selected classifiers. To better represent the performance of classifiers, some figures were created for classification accuracy, sensitivity, specificity, AUC, and the H-score metric. The performance of the ML algorithms on all features and selected features using the tenfold CV method is displayed in Table 5.

Table 5.

The results of tenfold CV for models’ performance metrics on full features and selected features

SVM (RBF) XGBoost SVM (Linear) RF MLP
Full features Selected features Full features Selected features Full features Selected features Full features Selected features Full features Selected features
Accuracy 0.624 0.817 0.652 0.8341 0.593 0.7807 0.622 0.814 0.590 0.7016
Specificity 0.619 0.7985 0.637 0.859 0.578 0.731 0.594 0.7733 0.591 0.7182
Sensitivity 0.611 0.8024 0.668 0.837 0.573 0.8117 0.627 0.801 0.586 0.708
AUC 0.584 0.7995 0.651 0.849 0.584 0.792 0.631 0.798 0.572 0.7051
H-Score 0.617 0.7925 0.653 0.832 0.580 0.7817 0.6287 0.7931 0.594 0.712

According to the results presented in Table 5, the performance of classifiers on the selected features was better than on full features. When the selected factors were included in the model, the results show that the XGBoost classifier yielded an accuracy of 83.4%, a sensitivity of 83.7%, a specificity of 85.9%, an AUC of 84.9%, and an H-score of 83.2%. While the KNN classifier for K = 7 obtained the mean accuracy of 67.98%, the mean sensitivity of 66%, a specificity of 70.2%, an AUC of 66.8%, and a mean H-score of 69.14% when all features were fed into the classifiers (Table 6). The results of the six best experiments of classifiers on the selected features are shown in Fig. 3.

Table 6.

The results of tenfold CV for models’ performance metrics on full features and selected features

KNN
K Accuracy Specificity Sensitivity AUC H-Score
Full features Selected features Full features Selected features Full features Selected features Full features Selected features Full features Selected features
1 0.664 0.7126 0.6737 0.7882 0.6587 0.733 0.6538 0.710 0.6481 0.6910
3 0.6538 0.7223 0.6819 0.7647 0.6597 0.7255 0.6767 0.7365 0.6837 0.7153
7 0.6798 0.7151 0.7022 0.735 0.6696 0.7427 0.6684 0.7523 0.6914 0.7261
9 0.6524 0.7369 0.6831 0.7813 0.661 0.7407 0.6944 0.7312 0.602 0.7231

Fig. 3.

Fig. 3

Comparison of the performance of the six best ML models on the selected features

According to Fig. 3, the performance of the XGBoost classifier was better than that of the five other algorithms (a mean accuracy of 83.7%, a mean specificity of 85.9%, an average sensitivity of 83.7%, an AUC of 84.9, and an H-score of 83.2). In Fig. 3, the worst performance was observed for the MLP classifier with an accuracy, specificity, sensitivity, AUC, and H-score of 70.1%, 71.8%, 70.5%, 70.8%, and 71.2%, respectively. The AUC and classification report of the XGBoost classifier, which was selected as the best classifier in the prediction of gastric cancer, are shown in Fig. 4.

Fig. 4.

Fig. 4

The classification report and ROC curve for the XGBoost classifier

Discussion

It is important to provide accurate and rapid screening for gastric cancer since this malignancy is very treatable when diagnosed in early phases. Therefore, implementing procedures for the screening and diagnosis of gastric cancer is highly beneficial. In this regard, a timely and reliable screening method enables rapid detection of the disease, and the subsequent timely interventions can help boost the likelihood of patient survival (2, 10). In this study, we developed non-invasive and cost-effective predictive models using six ML algorithms for gastric cancer risk assessment to distinguish high-risk patients with gastric cancer from the general population. Due to the fact that gastric cancer has multiple features with many potentially important confounders, it is a great challenge for clinicians to consider and analyze all the engaging features and decide on the patient's condition. It also raises the likelihood of a physician error during the decision-making process of disease diagnosis [38]. Thus, it is desirable to use an intelligent method that has the ability to learn the problem and generalize it to other situations. In this study, six methods of MLP, SVM (linear kernel, RBF kernel), KNN, RF, and XGBoost were proposed to classify gastric cancer patients. Based on the results, the XGBoost had the best performance in predicting gastric cancer risk in comparison with the other ML techniques using the stated evaluation metrics.

Several studies have been conducted with the aim of improving the early screening accuracy of gastric cancer through the use of ML. The predictive models in previous studies were developed based on diagnostic, laboratory, pathology, and imaging data and were not related to lifestyle data and individual habits and behaviors. Therefore, the advantage that distinguishes our study was that we obtained relatively significant results by applying ML methods based on data on the lifestyle features and behavior of individuals. Moreover, our study used feature selection to select the most significant lifestyle-based variables in order to maximize the capability of the models when compared to the analysis of all variables in the dataset. Feature selection enhances the accuracy, specificity, and sensitivity of the classifiers and decreases the running time of the predictive system. In this study, we used the ML algorithms due to the fact that these methods resulted in better predictions than the conventional statistical techniques when dealing with a large number of features with complicated relationships [39, 40]. Although statistical models can easily determine the relationship between dependent and independent variables, they cannot handle a large amount of variables with different types and intricate associations [41, 42]. If the aim of the study is to improve the performance of predictive models and the interpretation of models is of secondary importance, researchers prefer to develop ML models to achieve satisfactory predictions [40].

The main advantage of our study was that it estimated the risk of gastric cancer based on lifestyle-related factors. Some researchers have incessantly focused on medical equipment and detection reagents to improve the screening of gastric cancer, and the results of their studies were applied to clinical gastroscopy and biopsy [43, 44]. A few studies have combined genetic, proteomics, and molecular biology to detect gastric cancer [4548]. However, owing to their limitations, such as invasiveness, intricacy, high cost, or low adaptability, the diagnostic methods have not been widely adopted in clinical practice for gastric cancer screening. Tumor markers, e.g., CEA, CA199, CA125, and CA724, are generally used for the diagnosis of gastric cancer. But, the sensitivity and accuracy of these non-invasive features are not satisfactory [4951]. Contrary to the abovementioned studies, we applied ML techniques to stratify the risk of gastric cancer, which is a non-invasive approach. Patients were first examined by the optimal ML models developed, and then the high-risk cases were referred to specialized centers for further diagnostic procedures, such as endoscopy and pathology biopsy. The non-invasive gastric cancer screening approach developed in our study is highly adaptable and low-cost, which increases the coverage of gastric cancer screening in clinical practice.

Nevertheless, this study also had some limitations. First, the participants in the study included patients from a single care center, which limits the generalizability of the results to larger populations. Second, there was some subjective bias in selecting variables and examining lifestyle behavior that may affect the predictive results. Another limitation of this study was a retrospective analysis using registered data, which reduces the external validity of the results. Thus, future testing in a larger population is recommended.

Conclusions

This study utilized the routine available non-invasive features to implement six models for screening the risk of gastric cancer. The XGBoost model demonstrated better performance than the other ML models and can be applied to assist clinicians in the screening of gastric cancer risk in accordance with the Iranian health referral system and hierarchical leveling of healthcare services, which will improve the early screening of gastric cancer on a large scale. The ML models may identify high-risk patients with gastric cancer early, which draws the attention of clinicians and patients, and appropriate and timely interventions will be implemented to improve the patients’ survival chance and quality of life. This study can also aid clinical researchers in choosing and implementing the optimal prediction models and evaluating the main influencing features.

Acknowledgements

We thank the research deputy of the Abadan University of Medical Sciences for financially supporting this project. (Ethics code: IR.ABADANUMS.REC.1401.013).

Abbreviations

MLP

Multilayer perceptron

SVM

Support vector machine

KNN

Nearest neighbors

XGBoost

EXtreme gradient boosting

ML

Machine learning

AI

Artificial intelligence

SMOTE

Synthetic minority oversampling technique

Author contributions

HKA, MSH and MA: Conceptualization; Data curtain; Formal analysis; Investigation; Project administration; Resources; Supervision; Roles/Writing—original draft. HKA and MA: Funding acquisition; Methodology; Writing—review & editing. All authors read and approved the final manuscript.

Funding

Abadan University of Medical Sciences.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Declarations

Ethics approval and consent to participate

This article is extracted from a research project supported by the Abadan University of Medical Sciences (Ethics code: IR.ABADANUMS.REC.1401.013). The study was approved by the ethical committee of the Abadan University of Medical Sciences. All methods of the present study were performed in accordance with the relevant guidelines and regulations. Informed consent was obtained from all subjects and/or their legal guardian(s). Participation was voluntary, the consent was verbal, but all participants responded via email or text message to approve their participation. Participants had the right to withdraw from the study at any time without prejudice. All participants were required to sign a privacy agreement and study participation consent form before joining the expert panel. They were cognizant of the objectives of the study.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Mohammad Reza Afrash, Email: m.afrash@sbmu.ac.ir.

Mohsen Shafiee, Email: ikfyums@yahoo.com.

Hadi Kazemi-Arpanahi, Email: h.kazemi@abadanums.ac.ir.

References

  • 1.Chen Y, Zhang Y, Pan F, Liu J, Wang K, Zhang C, Cheng S, Lu L, Zhang W, Zhang Z. Breath analysis based on surface-enhanced Raman scattering sensors distinguishes early and advanced gastric cancer patients from healthy persons. ACS Nano. 2016;10(9):8169–8179. doi: 10.1021/acsnano.6b01441. [DOI] [PubMed] [Google Scholar]
  • 2.Farmanfarma KK, Mahdavifar N, Hassanipour S, Salehiniya H. Epidemiologic study of gastric cancer in Iran: a systematic review. Clin Exp Gastroenterol. 2020;13:511. doi: 10.2147/CEG.S256627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Isomoto H, Shikuwa S, Yamaguchi N, Fukuda E, Ikeda K, Nishiyama H, Ohnita K, Mizuta Y, Shiozawa J, Kohno S. Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study. Gut. 2009;58(3):331–336. doi: 10.1136/gut.2008.165381. [DOI] [PubMed] [Google Scholar]
  • 4.Fukunaga S, Nagami Y, Shiba M, Ominami M, Tanigawa T, Yamagami H, Tanaka H, Muguruma K, Watanabe T, Tominaga K. Long-term prognosis of expanded-indication differentiated-type early gastric cancer treated with endoscopic submucosal dissection or surgery using propensity score analysis. Gastrointest Endosc. 2017;85(1):143–152. doi: 10.1016/j.gie.2016.06.049. [DOI] [PubMed] [Google Scholar]
  • 5.Choi IJ, Lee JH, Kim Y-I, Kim CG, Cho S-J, Lee JY, Ryu KW, Nam B-H, Kook M-C, Kim Y-W. Long-term outcome comparison of endoscopic resection and surgery in early gastric cancer meeting the absolute indication for endoscopic resection. Gastrointest Endosc. 2015;81(2):333–341. doi: 10.1016/j.gie.2014.07.047. [DOI] [PubMed] [Google Scholar]
  • 6.Liu D, Wang X, Li L, Jiang Q, Li X, Liu M, Wang W, Shi E, Zhang C, Wang Y. Machine learning-based model for the prognosis of postoperative gastric cancer. Cancer Manag Res. 2022;14:135. doi: 10.2147/CMAR.S342352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Park CH, Kim EH, Chung H, Lee H, Park JC, Shin SK, Lee YC, An JY, Kim H-I, Cheong J-H. The optimal endoscopic screening interval for detecting early gastric neoplasms. Gastrointest Endosc. 2014;80(2):253–259. doi: 10.1016/j.gie.2014.01.030. [DOI] [PubMed] [Google Scholar]
  • 8.Zhu S-L, Dong J, Zhang C, Huang Y-B, Pan W. Application of machine learning in the diagnosis of gastric cancer based on noninvasive characteristics. PLoS ONE. 2020;15(12):e0244869. doi: 10.1371/journal.pone.0244869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Evans JA, Chandrasekhara V, Chathadi KV, Decker GA, Early DS, Fisher DA, Foley K, Hwang JH, Jue TL, Lightdale JR. The role of endoscopy in the management of premalignant and malignant conditions of the stomach. Gastrointest Endosc. 2015;82(1):1–8. doi: 10.1016/j.gie.2015.03.1967. [DOI] [PubMed] [Google Scholar]
  • 10.Taninaga J, Nishiyama Y, Fujibayashi K, Gunji T, Sasabe N, Iijima K, Naito T. Prediction of future gastric cancer risk using a machine learning algorithm and comprehensive medical check-up data: a case-control study. Sci Rep. 2019;9(1):1–9. doi: 10.1038/s41598-019-48769-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Zhang X, Li M, Chen S, Hu J, Guo Q, Liu R, Zheng H, Jin Z, Yuan Y, Xi Y. Endoscopic screening in Asian countries is associated with reduced gastric cancer mortality: a meta-analysis and systematic review. Gastroenterology. 2018;155(2):347–354. doi: 10.1053/j.gastro.2018.04.026. [DOI] [PubMed] [Google Scholar]
  • 12.Mei X, Lee H-C, Diao K-Y, Huang M, Lin B, Liu C, Xie Z, Ma Y, Robson PM, Chung M. Artificial intelligence–enabled rapid diagnosis of patients with COVID-19. Nat Med. 2020;26:1224–1228. doi: 10.1038/s41591-020-0931-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Liu Y, Lin D, Li L, Chen Y, Wen J, Lin Y, He X. Using machine-learning algorithms to identify patients at high risk of upper gastrointestinal lesions for endoscopy. J Gastroenterol Hepatol. 2021;6:2735–2744. doi: 10.1111/jgh.15530. [DOI] [PubMed] [Google Scholar]
  • 14.Alfayez AA, Kunz H, Lai AG. Predicting the risk of cancer in adults using supervised machine learning: a scoping review. BMJ Open. 2021;11(9):e047755. doi: 10.1136/bmjopen-2020-047755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Niu P-H, Zhao L-L, Wu H-L, Zhao D-B, Chen Y-T. Artificial intelligence in gastric cancer: application and future perspectives. World J Gastroenterol. 2020;26(36):5408. doi: 10.3748/wjg.v26.i36.5408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Zhou C, Hu J, Wang Y, Ji M-H, Tong J, Yang J-J, Xia H. A machine learning-based predictor for the identification of the recurrence of patients with gastric cancer after operation. Sci Rep. 2021;11(1):1–7. doi: 10.1038/s41598-021-81188-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Afrash MR, Khalili M, Salekde MS. A comparison of data mining methods for diagnosis and prognosis of heart disease. Int J Adv Intell Paradig. 2020;16(1):88–97. [Google Scholar]
  • 18.Liu M-M, Wen L, Liu Y-J, Cai Q, Li L-T, Cai Y-M. Application of data mining methods to improve screening for the risk of early gastric cancer. BMC Med Inform Decis Mak. 2018;18(5):23–32. doi: 10.1186/s12911-018-0689-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Cai Q, Zhu C, Yuan Y, Feng Q, Feng Y, Hao Y, Li J, Zhang K, Ye G, Ye L. Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study. Gut. 2019;68(9):1576–1587. doi: 10.1136/gutjnl-2018-317556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Safdari R, Arpanahi HK, Langarizadeh M, Ghazisaiedi M, Dargahi H, Zendehdel K. Design a fuzzy rule-based expert system to aid earlier diagnosis of gastric cancer. Acta Inform Med. 2018;26(1):19. doi: 10.5455/aim.2018.26.19-23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Su Y, Shen J, Qian H, Ma H, Ji J, Ma H, Ma L, Zhang W, Meng L, Li Z. Diagnosis of gastric cancer using decision tree classification of mass spectral data. Cancer Sci. 2007;98(1):37–43. doi: 10.1111/j.1349-7006.2006.00339.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Brindha SK, Kumar NS, Chenkual S, Lalruatfela S, Zomuana T, Ralte Z, Maitra A, Basu A, Nath P. Data mining for early gastric cancer etiological factors from diet-lifestyle characteristics. In: 2020 4th international conference on intelligent computing and control systems (ICICCS) 2020, IEEE; 2020. 65–73.
  • 23.Mortezagholi A, Khosravizadeh O, Menhaj MB, Shafigh Y, Kalhor R. Make intelligent of gastric cancer diagnosis error in Qazvin’s medical centers: using data mining method. Asian Pac J Cancer Prev. 2019;20(9):2607. doi: 10.31557/APJCP.2019.20.9.2607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Zhu Y, Wang Q-C, Xu M-D, Zhang Z, Cheng J, Zhong Y-S, Zhang Y-Q, Chen W-F, Yao L-Q, Zhou P-H. Application of convolutional neural network in the diagnosis of the invasion depth of gastric cancer based on conventional endoscopy. Gastrointest Endosc. 2019;89(4):806–815. doi: 10.1016/j.gie.2018.11.011. [DOI] [PubMed] [Google Scholar]
  • 25.Hirasawa T, Aoyama K, Tanimoto T, Ishihara S, Shichijo S, Ozawa T, Ohnishi T, Fujishiro M, Matsuo K, Fujisaki J. Application of artificial intelligence using a convolutional neural network for detecting gastric cancer in endoscopic images. Gastric Cancer. 2018;21(4):653–660. doi: 10.1007/s10120-018-0793-2. [DOI] [PubMed] [Google Scholar]
  • 26.Yasar A, Saritas I, Korkmaz H. Computer-aided diagnosis system for detection of stomach cancer with image processing techniques. J Med Syst. 2019;43(4):1–11. doi: 10.1007/s10916-019-1203-y. [DOI] [PubMed] [Google Scholar]
  • 27.Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14(1):26. doi: 10.5114/pg.2018.80001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Uddin S, Khan A, Hossain ME, Moni MA. Comparing different supervised machine learning algorithms for disease prediction. BMC Med Inform Decis Mak. 2019;19(1):1–16. doi: 10.1186/s12911-019-1004-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Raschka S. Model evaluation, model selection, and algorithm selection in machine learning. 2018. Preprint http://arxiv.org/abs/181112808.
  • 30.Anguita D, Ghio A, Greco N, Oneto L, Ridella S. Model selection for support vector machines: advantages and disadvantages of the machine learning theory. In: The 2010 international joint conference on neural networks (IJCNN) 2010, IEEE; 2010. pp. 1–8.
  • 31.Guo G, Wang H, Bell D, Bi Y, Greer K. KNN model-based approach in classification. In: OTM confederated international conferences "on the move to meaningful internet systems" 2003, Springer; 2003. pp. 986–996.
  • 32.Pinkus A. Approximation theory of the MLP model in neural networks. Acta Numer. 1999;8:143–195. doi: 10.1017/S0962492900002919. [DOI] [Google Scholar]
  • 33.Chen T, He T, Benesty M, Khotilovich V, Tang Y, Cho H, Chen K. Xgboost: extreme gradient boosting. R Package Version 0.4-2. 2015;1(4):1–4. [Google Scholar]
  • 34.Blagus R, Lusa L. SMOTE for high-dimensional class-imbalanced data. BMC Bioinform. 2013;14(1):1–16. doi: 10.1186/1471-2105-14-106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Mohammed AJ, Hassan MM, Kadir DH. Improving classification performance for a novel imbalanced medical dataset using SMOTE method. Int J. 2020;9(3):3161–3172. [Google Scholar]
  • 36.Ahmad T, Aziz MN. Data preprocessing and feature selection for machine learning intrusion detection systems. ICIC Express Lett. 2019;13(2):93–101. [Google Scholar]
  • 37.Rosario SF, Thangadurai K. RELIEF: feature selection approach. Int J Innov Res Dev. 2015;4(11).
  • 38.Mahmoodi SA, Mirzaie K, Mahmoudi SM. A new algorithm to extract hidden rules of gastric cancer data based on ontology. Springerplus. 2016;5(1):1–21. doi: 10.1186/s40064-016-1943-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Ture M, Tokatli F, Omurlu IK. The comparisons of prognostic indexes using data mining techniques and Cox regression analysis in the breast cancer data. Expert Syst Appl. 2009;36(4):8247–8254. doi: 10.1016/j.eswa.2008.10.014. [DOI] [Google Scholar]
  • 40.Delen D, Walker G, Kadam A. Predicting breast cancer survivability: a comparison of three data mining methods. Artif Intell Med. 2005;34(2):113–127. doi: 10.1016/j.artmed.2004.07.002. [DOI] [PubMed] [Google Scholar]
  • 41.Kim YS. Performance evaluation for classification methods: a comparative simulation study. Expert Syst Appl. 2010;37(3):2292–2306. doi: 10.1016/j.eswa.2009.07.043. [DOI] [Google Scholar]
  • 42.Kim YS. Comparison of the decision tree, artificial neural network, and linear regression methods based on the number and types of independent variables and sample size. Expert Syst Appl. 2008;34(2):1227–1234. doi: 10.1016/j.eswa.2006.12.017. [DOI] [Google Scholar]
  • 43.Yamaguchi Y, Nagata Y, Hiratsuka R, Kawase Y, Tominaga T, Takeuchi S, Sakagami S, Ishida S. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels-the ABC method. Digestion. 2016;93(1):13–18. doi: 10.1159/000441742. [DOI] [PubMed] [Google Scholar]
  • 44.Ali Z, Deng Y, Ma C. Progress of research in gastric cancer. J Nanosci Nanotechnol. 2012;12(11):8241–8248. doi: 10.1166/jnn.2012.6692. [DOI] [PubMed] [Google Scholar]
  • 45.Jang JS, Choi SR, Han SY, Roh MH, Lee JH, Lee SW, Jeung JS, Kim MC, Son YK, Baek YH. Predictive significance of serum IL-6, VEGF, and CRP in gastric adenoma and mucosal carcinoma before endoscopic submucosal dissection. Korean J Gastroenterol. 2009;54(2):99–107. doi: 10.4166/kjg.2009.54.2.99. [DOI] [PubMed] [Google Scholar]
  • 46.Zhou B, Zhou Z, Chen Y, Deng H, Cai Y, Rao X, Yin Y, Rong L. Plasma proteomics-based identification of novel biomarkers in early gastric cancer. Clin Biochem. 2020;76:5–10. doi: 10.1016/j.clinbiochem.2019.11.001. [DOI] [PubMed] [Google Scholar]
  • 47.Wu J, Li G, Wang Z, Yao Y, Chen R, Pu X, Wang J. Circulating microRNA-21 is a potential diagnostic biomarker in gastric cancer. Dis Markers 2015, 2015. [DOI] [PMC free article] [PubMed]
  • 48.Watanabe Y, Kim HS, Castoro RJ, Chung W, Estecio MR, Kondo K, Guo Y, Ahmed SS, Toyota M, Itoh F. Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes. Gastroenterology. 2009;136(7):2149–2158. doi: 10.1053/j.gastro.2009.02.085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Zhu Y, Ge S, Zhang L, Wang X, Xing X, Hu Y, Li Y, Jia Y, Lin Y, Fan B. Clinical value of serum CEA, CA19–9, CA72–4 and CA242 in the diagnosis and prognosis of gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi= Chin J Gastrointest Surg. 2012;15(2):161–164. [PubMed] [Google Scholar]
  • 50.Shitrit D, Zingerman B, Shitrit ABG, Shlomi D, Kramer MR. Diagnostic value of CYFRA 21–1, CEA, CA 19–9, CA 15–3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature. Oncologist. 2005;10(7):501–507. doi: 10.1634/theoncologist.10-7-501. [DOI] [PubMed] [Google Scholar]
  • 51.Liang Y, Wang W, Fang C, Raj SS, Hu W-M, Li Q-W, Zhou Z-W. Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer. Oncotarget. 2016;7(31):49565. doi: 10.18632/oncotarget.10391. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.


Articles from BMC Gastroenterology are provided here courtesy of BMC

RESOURCES